Route 92 Medical

Route 92 Medical

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.route92medical.com

Last Round

Series F

Extension

Apr 20, 2026

Total Funding Raised

$228.76M

Momentum Score

25 /100

Company Overview

Route 92 is a medical technology company that develops innovative devices for treating stroke and related conditions, including a percutaneous catheter, a rapid aspiration thrombectomy system, and intra-cerebral implant delivery to enhance patient recovery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mechanical thrombectomyischemic stroke treatmentreperfusion systemaspiration catheterneurovascular interventionsclot retrievalendovascular thrombectomyneurovascular devicesfirst pass effectstroke interventionmedtechdelivery catheteraccess sheathclot aspirationstroke care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Route 92 Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Route 92 Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series F ExtensionApr 20, 2026
Series FSep 23, 2024
Series FNov 16, 2023
Series EDec 14, 2021
DebtDec 14, 2021
Series D
May 10, 2019

Key People

Founding team and executive leadership

John Miller

Chief Technology Officer

Executive Team

Kirsten Valley

COO

Executive Team

Route 92 Medical Investors

Notable investors and investment history

InvestorRounds
Runway Growth CapitalDebt
The Vertical GroupSeries E, Series F Extension, Series A, Series F
InnovaHealth PartnersSeries F Extension, Series F, Series E
U.S. Venture PartnersSeries E, Series F Extension, Series A, Series F
Norwest Venture PartnersSeries F Extension, Series F, Series E
Novo HoldingsSeries F Extension, Series F
SectoralSeries F Extension, Series F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    $50M round completed.

  • Apr 10, 2026

    Moving headquarters to Utah as part of a $5 million expansion and new manufacturing operation.

Route 92 Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Route 92 Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Route 92 Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range189
Year Founded2015
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.